Please enter the keyword
Professor Gong Qiyong of Radiology inducted as AIMBE fellow

from clipboard

Recently, the American Institute for Medical and Biological Engineering (AIMBE) announced its 2024 class of newly elected Fellows, which included 152 distinguished scholars and four Chinese academics. Professor Gong Qiyong from WCH’s Radiology Department was honored with this prestigious recognition.


Established in 1991, AIMBE, headquartered in Washington D.C., is a renowned non-profit academic organization in the international field of medical and biological engineering. It is dedicated to advancing the field to foster societal progress. AIMBE brings together the top 2% of scholars in medical and biological engineering worldwide, representing the most accomplished individuals in the field.


Professor Gong Qiyong currently serves as the President of West China Xiamen Hospital, Vice President of West China School of Medicine/West China Hospital, Sichuan University, Director of the Imaging Center, and Secretary-General of the Clinical Medicine Discipline Evaluation Group of the Academic Degrees Committee of the State Council. He has previously held positions as the Chair of the Mental MR Study Group of the International Society for Magnetic Resonance in Medicine (ISMRM) and President of the Overseas Chinese Society for Magnetic Resonance in Medicine (OCSMRM). Professor Gong has been invited to edit the North American radiologist training textbook "Psychoradiology". He is also the editor-in-chief of the journal "Psychoradiology", deputy editor-in-chief of "The American Journal of Psychiatry", and an editorial board member of "Neuroradiology".


The selection process for AIMBE Fellows is rigorous and authoritative. Each year, candidates are nominated by existing Fellows, undergo two rounds of screening, and are ultimately elected by a vote of the entire Fellow body. This honor is the highest academic accolade in the field of medical and biological engineering in the United States, with significant impact on biomedical science, medical device development, disease treatment, and the formulation of public health policies.